These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27354175)

  • 1. The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury.
    Sevelsted Møller L; Fialla AD; Schierwagen R; Biagini M; Liedtke C; Laleman W; Klein S; Reul W; Koch Hansen L; Rabjerg M; Singh V; Surra J; Osada J; Reinehr R; de Muckadell OB; Köhler R; Trebicka J
    Sci Rep; 2016 Jun; 6():28770. PubMed ID: 27354175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
    Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
    Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.
    Hubel E; Saroha A; Park WJ; Pewzner-Jung Y; Lavoie EG; Futerman AH; Bruck R; Fishman S; Dranoff JA; Shibolet O; Zvibel I
    Am J Pathol; 2017 Jan; 187(1):122-133. PubMed ID: 27842214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease.
    Paka L; Smith DE; Jung D; McCormack S; Zhou P; Duan B; Li JS; Shi J; Hao YJ; Jiang K; Yamin M; Goldberg ID; Narayan P
    World J Gastroenterol; 2017 Jun; 23(23):4181-4190. PubMed ID: 28694658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.
    Klein S; Rick J; Lehmann J; Schierwagen R; Schierwagen IG; Verbeke L; Hittatiya K; Uschner FE; Manekeller S; Strassburg CP; Wagner KU; Sayeski PP; Wolf D; Laleman W; Sauerbruch T; Trebicka J
    Gut; 2017 Jan; 66(1):145-155. PubMed ID: 26385087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.
    Granzow M; Schierwagen R; Klein S; Kowallick B; Huss S; Linhart M; Mazar IG; Görtzen J; Vogt A; Schildberg FA; Gonzalez-Carmona MA; Wojtalla A; Krämer B; Nattermann J; Siegmund SV; Werner N; Fürst DO; Laleman W; Knolle P; Shah VH; Sauerbruch T; Trebicka J
    Hepatology; 2014 Jul; 60(1):334-48. PubMed ID: 24619965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory and anti-fibrotic effects of modafinil in nonalcoholic liver disease.
    Choi S; Kim JA; Li H; Jo SE; Lee H; Kim TH; Kim M; Kim SJ; Suh SH
    Biomed Pharmacother; 2021 Dec; 144():112372. PubMed ID: 34794237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C/EBP-α ameliorates CCl(4)-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo.
    Tao LL; Cheng YY; Ding D; Mei S; Xu JW; Yu J; Ou-Yang Q; Deng L; Chen Q; Li QQ; Xu ZD; Liu XP
    Apoptosis; 2012 May; 17(5):492-502. PubMed ID: 22307857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids Have Opposing Effects on Liver Fibrosis in Hepatic Stellate and Immune Cells.
    Kim KH; Lee JM; Zhou Y; Harpavat S; Moore DD
    Mol Endocrinol; 2016 Aug; 30(8):905-16. PubMed ID: 27355192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.
    Borkham-Kamphorst E; Drews F; Weiskirchen R
    Liver Int; 2011 May; 31(5):656-65. PubMed ID: 21457438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matricellular protein periostin contributes to hepatic inflammation and fibrosis.
    Huang Y; Liu W; Xiao H; Maitikabili A; Lin Q; Wu T; Huang Z; Liu F; Luo Q; Ouyang G
    Am J Pathol; 2015 Mar; 185(3):786-97. PubMed ID: 25541330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.
    Tan Z; Qian X; Jiang R; Liu Q; Wang Y; Chen C; Wang X; Ryffel B; Sun B
    J Immunol; 2013 Aug; 191(4):1835-44. PubMed ID: 23842754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.
    Anumanthan G; Gupta S; Fink MK; Hesemann NP; Bowles DK; McDaniel LM; Muhammad M; Mohan RR
    PLoS One; 2018; 13(3):e0192145. PubMed ID: 29554088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Gab1 adaptor protein in hepatocytes aggravates experimental liver fibrosis in mice.
    Kizu T; Yoshida Y; Furuta K; Ogura S; Egawa M; Chatani N; Hamano M; Takemura T; Ezaki H; Kamada Y; Nishida K; Nakaoka Y; Kiso S; Takehara T
    Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(7):G613-24. PubMed ID: 25617348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of DJ-1 Ameliorates Liver Fibrosis through Inhibition of Hepatic ROS Production and Inflammation.
    Yu Y; Sun X; Gu J; Yu C; Wen Y; Gao Y; Xia Q; Kong X
    Int J Biol Sci; 2016; 12(10):1225-1235. PubMed ID: 27766037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis.
    Son G; Iimuro Y; Seki E; Hirano T; Kaneda Y; Fujimoto J
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G631-9. PubMed ID: 17640975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrogenic role of the cannabinoid receptor CB2 in the liver.
    Julien B; Grenard P; Teixeira-Clerc F; Van Nhieu JT; Li L; Karsak M; Zimmer A; Mallat A; Lotersztajn S
    Gastroenterology; 2005 Mar; 128(3):742-55. PubMed ID: 15765409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of matrilin-2 expression in murine hepatic stellate cells during liver injury has no effect on fibrosis formation and resolution.
    Hintermann E; Bayer M; Pfeilschifter JM; Deák F; Kiss I; Paulsson M; Christen U
    Liver Int; 2015 Apr; 35(4):1265-73. PubMed ID: 24905825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
    Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
    Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.